Innate Pharma S.a. buy krebskrebs
Start price
22.03.21
/
50%
€3.72
Target price
22.03.22
€4.00
Performance (%)
-22.04%
End price
23.03.22
€2.90
Summary
This prediction ended on 23.03.22 with a price of €2.90. The price of Innate Pharma S.a. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -22.04%. krebskrebs has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Innate Pharma S.a. | - | - | - | - |
iShares Core DAX® | 0.347% | 2.173% | 18.599% | 21.611% |
iShares Nasdaq 100 | 0.715% | 0.138% | 26.542% | 40.349% |
iShares Nikkei 225® | 1.522% | 2.003% | 13.220% | 3.542% |
iShares S&P 500 | 0.631% | 1.633% | 25.009% | 42.942% |
Comments by krebskrebs for this prediction
In the thread Innate Pharma S.a. diskutieren
Buy mit Kursziel 4,0
In the thread Trading Innate Pharma S.a.
Die von krebskrebs gewählte maximale Laufzeit wurde überschritten